Cholinesterase inhibitors from botanicals

Area of Science:

• Neuroscience
• Pharmacology
• Natural Products Chemistry

Background:

• Alzheimer's disease (AD) is characterized by progressive neurodegeneration and loss of cholinergic synapses.
• Reduced acetylcholine (ACh) levels are critical in dementia development.
• Restoring ACh levels by inhibiting cholinesterases is a key therapeutic strategy.

Purpose of the Study:

• To review advances in identifying natural cholinesterase inhibitors from medicinal plants.
• To present structures of key phytoconstituents with cholinesterase inhibitory activity.
• To discuss future research directions in this field.

Main Methods:

• Literature review of scientific publications on cholinesterase inhibitors.
• Identification and compilation of phytoconstituents with reported inhibitory activity.
• Collection of chemical structures from online databases (e.g., www.Chemspider.com).

Main Results:

• Numerous phytoconstituents with Acetylcholinesterase (AChE) and Butyrylcholinesterase (BChE) inhibitory activity have been isolated from medicinal plants.
• Key compounds and their structures are presented.
• The review synthesizes current knowledge on plant-derived cholinesterase inhibitors.

Conclusions:

• Medicinal plants are a rich source of potential therapeutic agents for Alzheimer's disease.
• Phytoconstituents targeting cholinesterases offer a promising avenue for dementia treatment.
• Further research into these natural compounds is warranted for drug development.